Mediwatch secures five year global distribution agreement with Inverness Medical Innovations
19-Mar-2009 -
Mediwatch plc has signed a five-year agreement for the worldwide distribution of PSAwatch, its flagship point-of-care total PSA measuring system for prostate cancer, with Inverness Medical Innovations, Inc. According to the company, Inverness has an extensive global sales-force which will ...
diagnostics
prostate cancer